For a third consecutive year, the Research Institute of the MUHC (RI-MUHC) is one of the top 40 research hospitals in Canada. The recent rankings released by Re$earch Infosource Inc. have the RI-MUHC claiming the 2nd overall spot in the country. The results were tallied based on research intensity, which includes both grants and contracts.
Diagnosing colorectal cancer (CRC) is complex; it relies on significant invasive tests and subjective evaluations. This process may soon become much easier thanks to a medical breakthrough by scientists at the Research Institute of the McGill University Health Centre (RI-MUHC). The researchers have identified genetic changes in the colon lining, or mucosa, in colorectal cancer patients that could be used as biomarkers of the disease. That will allow doctors to diagnose patients earlier, more accurately and less invasively. The study, recently published online, in Cancer Prevention Research, has implications for the nearly one million people diagnosed annually worldwide.
Today, the Cancer Research Society, the Ministère de l’Enseignement supérieur, de la Recherche, de la Science et de la Technologie (MESRST), Université Laval, and the Research Institute of the McGill University Health Centre (RI MUHC) jointly announced a $3.7-million investment into environment-cancer research. From this amount, $2.7 million will go towards the research project of Dr. Yves Fradet, from Université Laval, and Dr. Armen Aprikian, from the RI MUHC, to study the relationship between lifestyle, biomarkers and prostate cancer risk. The remaining $1 million from the MESRST and the Cancer Research Society will be used to recruit epidemiologists who specialize in environment-cancer research. This investment is part of the Cancer Research Society's GRePEC program (a research and prevention group in environment-cancer), in collaboration with the Fonds de recherche du Québec – Santé (FRQS).
The Research Institute of the McGill University Health Centre (RI-MUHC) and McGill University congratulate the team led by Dr. Nitika Pant Pai for receiving the international 2013 Accelerating Science Award Program (ASAP). The team won global recognition for developing an innovative self-test screening strategy for the Human immunodeficiency virus (HIV). The award, funded by Public Library of Science (PLoS), Google and Wellcome Trust, recognizes scientific innovations borne out of Open Access research that address real world challenges. Dr. Nitika Pant Pai received the $30,000 award today at the World Bank in Washington, DC.
Chest pain is recognized as a symptom of heart troubles, but one out of five women aged 55 years or less having a heart attack do not experience this symptom, according to a study led by the Research Institute of the McGill University Health Centre (RI-MUHC). The research findings, gathered from partner institutions across Canada including the University of British Columbia (UBC), are the first to describe this phenomenon in young women. The study, published in JAMA Internal Medicine, has implications for emergency room healthcare professionals and for at-risk individuals, as seconds matter when it comes to the accurate diagnosis and treatment of heart attack.
Genetic analysis of a handful of patients with an undiagnosed condition leads to discovery of new disease
An international research team, including scientists from the Research Institute of the McGill University Health Centre (RI MUHC), has identified a new disease related to an inability to process vitamin B12. The discovery is important because it could help doctors diagnose the disease and, eventually, could lead to prevention or treatment. The discovery, published today in The American Journal of Human Genetics, illustrates the complex and relatively new realm of medical discovery where researchers peer into the genetic make-up of patients to discern what went wrong to cause a disease.
Research from McGill University suggests that people who are vulnerable to developing alcoholism exhibit a distinctive brain response when drinking alcohol, according to a new study by Prof. Marco Leyton, of McGill University’s Department of Psychiatry. Compared to people at low risk for alcohol-use problems, those at high risk showed a greater dopamine response in a brain pathway that increases desire for rewards. These findings, published in the journal Alcoholism: Clinical & Experimental Research, could help shed light on why some people are more at risk of suffering from alcoholism and could mark an important step toward the development of treatment options.
The very system that is meant to protect the body from invasion may be a traitor. These new findings of a study, led by investigators at the Research Institute of the McGill University Health Centre (RI-MUHC), reveal that infection-fighting white blood cells play a role in activating cancer cells and facilitating their spread to secondary tumours. This research, published today in the Journal of Clinical Investigation has significant implications for both the diagnosis and treatment of cancer.
Taking a calcium supplement of up to 1,000 mg per day can help women live longer, according to a study whose lead author was Lisa Langsetmo, a Ph.D. Research Associate at McGill University, and whose senior author was Prof. David Goltzman, Division of Endocrinology and Metabolism in the Department of Medicine of the Faculty of Medicine and researcher in the Musculoskeletal Disorders axis at the Research Institute of the McGill University Health Centre (RI-MUHC). Their findings are published in the Journal of Clinical Endocrinology & Metabolism (JCEM).